Amina Ali

1.1k total citations
21 papers, 700 citations indexed

About

Amina Ali is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology. According to data from OpenAlex, Amina Ali has authored 21 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 8 papers in Cancer Research and 6 papers in Molecular Biology. Recurrent topics in Amina Ali's work include Prostate Cancer Treatment and Research (15 papers), Prostate Cancer Diagnosis and Treatment (10 papers) and Molecular Biology Techniques and Applications (3 papers). Amina Ali is often cited by papers focused on Prostate Cancer Treatment and Research (15 papers), Prostate Cancer Diagnosis and Treatment (10 papers) and Molecular Biology Techniques and Applications (3 papers). Amina Ali collaborates with scholars based in United States, United Kingdom and China. Amina Ali's co-authors include Shiv Srivastava, David G. McLeod, Isabell A. Sesterhenn, Yongmei Chen, György Petrovics, Inger L. Rosner, Jennifer Cullen, Judd W. Moul, Timothy C. Brand and H. Jeffrey Lawrence and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and The Journal of Urology.

In The Last Decade

Amina Ali

21 papers receiving 682 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amina Ali United States 11 483 254 230 94 80 21 700
Hans de Jong Netherlands 7 650 1.3× 284 1.1× 331 1.4× 48 0.5× 52 0.7× 14 823
G.H.J.M. Leyten Netherlands 8 623 1.3× 359 1.4× 369 1.6× 47 0.5× 57 0.7× 12 850
Petrea Hodge United States 3 523 1.1× 266 1.0× 278 1.2× 33 0.4× 34 0.4× 5 689
Anamaria Crisan Canada 6 586 1.2× 206 0.8× 349 1.5× 10 0.1× 64 0.8× 15 711
Mari Nakazawa United States 10 836 1.7× 334 1.3× 434 1.9× 28 0.3× 265 3.3× 25 1.0k
Jarred Tanksley United States 11 80 0.2× 281 1.1× 62 0.3× 120 1.3× 97 1.2× 14 522
Bavanthi Balakrishnar Australia 10 186 0.4× 160 0.6× 114 0.5× 24 0.3× 195 2.4× 25 469
Patrick Lebok Germany 13 177 0.4× 268 1.1× 131 0.6× 9 0.1× 191 2.4× 32 548
Irene Casanova‐Salas Spain 10 182 0.4× 311 1.2× 302 1.3× 8 0.1× 77 1.0× 27 623
Andrew Erickson Finland 13 254 0.5× 116 0.5× 91 0.4× 6 0.1× 122 1.5× 40 417

Countries citing papers authored by Amina Ali

Since Specialization
Citations

This map shows the geographic impact of Amina Ali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amina Ali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amina Ali more than expected).

Fields of papers citing papers by Amina Ali

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amina Ali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amina Ali. The network helps show where Amina Ali may publish in the future.

Co-authorship network of co-authors of Amina Ali

This figure shows the co-authorship network connecting the top 25 collaborators of Amina Ali. A scholar is included among the top collaborators of Amina Ali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amina Ali. Amina Ali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Yubing, Rassim Khelifa, Amina Ali, et al.. (2025). Diagnostic technologies for neuroblastoma. Lab on a Chip. 25(15). 3630–3664. 1 indexed citations
2.
Rosenberg, Matt T., Albert Dobi, Amina Ali, et al.. (2024). Filamin A Is a Prognostic Serum Biomarker for Differentiating Benign Prostatic Hyperplasia from Prostate Cancer in Caucasian and African American Men. Cancers. 16(4). 712–712. 2 indexed citations
3.
Feeney, Claire, Vickie Lee, Parizad Avari, et al.. (2024). Extraocular muscle Diffusion Weighted Imaging as a quantitative metric of posterior orbital involvement in thyroid associated orbitopathy. Insights into Imaging. 15(1). 183–183. 5 indexed citations
5.
Kohaar, Indu, Yongmei Chen, Amina Ali, et al.. (2020). Abstract A111: Urine-based gene expression panels with focus on prostate cancer in African Americans. Cancer Epidemiology Biomarkers & Prevention. 29(6_Supplement_1). A111–A111. 1 indexed citations
6.
Kohaar, Indu, Yongmei Chen, Talaibek Borbiev, et al.. (2020). A Urine Exosome Gene Expression Panel Distinguishes between Indolent and Aggressive Prostate Cancers at Biopsy. The Journal of Urology. 205(2). 420–425. 31 indexed citations
8.
Kohaar, Indu, Yongmei Chen, Lakshmi Ravindranath, et al.. (2018). Abstract 1230: Association of common germline variants with TMPRSS2-ERG gene fusion status in prostate cancer. Cancer Research. 78(13_Supplement). 1230–1230. 1 indexed citations
9.
Rastogi, Anshu, Amina Ali, Shyh‐Han Tan, et al.. (2017). Autoantibodies against oncogenic ERG protein in prostate cancer: potential use in diagnosis and prognosis in a panel with C-MYC, AMACR and HERV-K Gag. Genes & Cancer. 7(11-12). 394–413. 18 indexed citations
10.
Rastogi, Anshu, Amina Ali, Lakshmi Ravindranath, et al.. (2016). MP02-05 AUTOANTIBODIES AGAINST ERG, AMACR, C-MYC AND HERV GAG IN THE SERA OF PROSTATE CANCER PATIENTS: POTENTIAL USE IN DIAGNOSIS/PROGNOSIS. The Journal of Urology. 195(4S). 1 indexed citations
11.
Petrovics, György, Lakshmi Ravindranath, Yongmei Chen, et al.. (2016). MP39-18 HIGHER FREQUENCY OF GERMLINE BRCA1 AND BRCA2 MUTATIONS IN AFRICAN AMERICAN PROSTATE CANCER. The Journal of Urology. 195(4S). 4 indexed citations
12.
Nickens, Kristen P., Amina Ali, Shyh‐Han Tan, et al.. (2015). Prostate cancer marker panel with single cell sensitivity in urine. The Prostate. 75(9). 969–975. 23 indexed citations
14.
Sharad, Shashwat, Lakshmi Ravindranath, Michael C. Haffner, et al.. (2014). Methylation of thePMEPA1gene, a negative regulator of the androgen receptor in prostate cancer. Epigenetics. 9(6). 918–927. 23 indexed citations
15.
Whitman, Eric J., Mark M. Pomerantz, Yongmei Chen, et al.. (2010). Prostate Cancer Risk Allele Specific for African Descent Associates with Pathologic Stage at Prostatectomy. Cancer Epidemiology Biomarkers & Prevention. 19(1). 1–8. 29 indexed citations
16.
Ali, Amina, Bungo Furusato, Paul O. P. Ts’o, et al.. (2010). Assessment of circulating tumor cells (CTCs) in prostate cancer patients with low-volume tumors. Pathology International. 60(10). 667–672. 4 indexed citations
17.
Rice, Kevin R., Yongmei Chen, Amina Ali, et al.. (2010). Evaluation of the ETS-Related Gene mRNA in Urine for the Detection of Prostate Cancer. Clinical Cancer Research. 16(5). 1572–1576. 43 indexed citations
18.
Whitman, Eric J., Jack Groskopf, Amina Ali, et al.. (2008). PCA3 Score Before Radical Prostatectomy Predicts Extracapsular Extension and Tumor Volume. The Journal of Urology. 180(5). 1975–1979. 129 indexed citations
19.
Gao, Chunling, Sudhir Rawal, Leon Sun, et al.. (2003). Diagnostic potential of prostate-specific antigen expressing epithelial cells in blood of prostate cancer patients.. PubMed. 9(7). 2545–50. 27 indexed citations
20.
Bañez, Lionel L., P Prasanna, Leon Sun, et al.. (2003). Diagnostic Potential of Serum Proteomic Patterns in Prostate Cancer. The Journal of Urology. 170(2). 442–446. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026